Impacts of Mutant TP53 Variant Allelic Frequency in Newly Diagnosed AML
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Blood Advances
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Prognostic and Therapeutic Impacts of Mutant TP53 Variant Allelic Frequency in Newly Diagnosed Acute Myeloid Leukemia
Blood Adv 2020 Nov 24;4(22)5681-5689, NJ Short, G Montalban-Bravo, H Hwang, J Ning, MJ Franquiz, R Kanagal-Shamanna, KP Patel, CD DiNardo, F Ravandi, G Garcia-Manero, K Takahashi, M Konopleva, N Daver, GC Issa, M Andreeff, H Kantarjian, TM KadiaFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.